Home » Newsletters » BioWorld

BioWorld

Nov. 9, 1995

View Archived Issues

MEDAREX RAISES $11M IN DIRECT PLACEMENT OF 2.2M SHARES

OTHER NEWS TO NOTE

TERRAPIN RAISES $11.7M IN PRIVATE FINANCING

CONGRESSIONAL WATCHDOG GROUP ABSOLVES FDA OF ITS SINS

FDA PANEL APPROVES D4T BUT ASKS FOR MORE DATA

ARRIS PHARMACEUTICALS ACQUIRES KHEPRI FOR $21M IN STOCK

CONFERENCE GENETICS INSTITUTE BEGINS IL-11 PHASE III; IL- 12 PROBLEMS

KNOCKOUT MICE RAISE DOUBTS ON HOW ASPIRIN, NSAIDS WORK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026